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Original Article 
Simple non-laboratory- and laboratory-based risk assessment algorithms and nomogra
m for detecting undiagnosed diabetes mellitus 
Carlos K.H. WONG,1 Shing-Chung SIU,3 Eric Y.F. WAN,1 Fang-Fang JIAO,1 Esther Y.T. YU,
1 Colman S.C. FUNG,1 Ka-Wai WONG,3 Angela Y.M. LEUNG,2 and Cindy L.K. LAM1 
1Department of Family Medicine and Primary Care, 2School of Nursing, The University of Ho
ng Kong, and 3Department of Medicine and Rehabilitation, Tung Wah Eastern Hospital, Hong
 Kong 
 
Abstract 
Background: The aim of the present study was to develop a simple nomogram that can be u
sed to predict the risk of diabetes mellitus (DM) in the asymptomatic non-diabetic subjects ba
sed on non-laboratory- and laboratory-based risk algorithms. 
Methods: Anthropometric data, plasma fasting glucose, full lipid profile, exercise habits, an
d family history of DM were collected from Chinese non-diabetic subjects aged 18–70 years. 
Logistic regression analysis was performed on a random sample of 2518 subjects to construct 
non-laboratory- and laboratory-based risk assessment algorithms for detection of undiagnosed
 DM; both algorithms were validated on data of the remaining sample (n = 839). The Hosme
r–Lemeshow test and area under the receiver operating characteristic (ROC) curve (AUC) wer
e used to assess the calibration and discrimination of the DM risk algorithms. 
Results: Of 3357 subjects recruited, 271 (8.1%) had undiagnosed DM defined by fasting gl
ucose ≥7.0 mmol/L or 2-h post-load plasma glucose ≥11.1 mmol/L after an oral glucose tolera
nce test. The non-laboratory-based risk algorithm, with scores ranging from 0 to 33, included 
age, body mass index, family history of DM, regular exercise, and uncontrolled blood pressur
e; the laboratory-based risk algorithm, with scores ranging from 0 to 37, added triglyceride le
vel to the risk factors. Both algorithms demonstrated acceptable calibration (Hosmer–Lemesh
ow test: P = 0.229 and P = 0.483) and discrimination (AUC 0.709 and 0.711) for detection of 
undiagnosed DM.  
Conclusion: A simple-to-use nomogram for detecting undiagnosed DM has been developed
 using validated non-laboratory-based and laboratory-based risk algorithms. 
 
• Significant findings of the study: Validated non-laboratory- and laboratory-based risk 
assessment algorithms were developed for the prediction of undiagnosed DM in a Chi
nese population. The optimal cut-off point on the ROC curve was 18 for the detection 
of undiagnosed DM in both algorithms. 
• What this study adds: The simple and user-friendly nomogram was constructed to ena
ble clinicians to estimate an individual’s risk of DM and thus to promote targeted scree
ning for DM among high-risk individuals in the primary care and community settings. 
 
Key words: calibration, discrimination, nomogram, risk algorithm, undiagnosed diabetes, vali
dation. 
 
<A>Introduction 
Diabetes mellitus (DM) is highly prevalent and has become one of the major disease burdens 
worldwide.1 In particular, undiagnosed DM is associated with a higher risk of diabetes-related
 complications2 and mortality3 compared with normal glucose tolerance because of the lack of
 awareness of high blood glucose levels and delayed disease management. Early detection of 
DM through periodic screening has been recommended4 for high-risk individuals using 75-g o
ral glucose tolerance tests (OGTT), fasting plasma glucose (FPG) tests or HbA1c levels. In a r
ecent cost-effectiveness analysis, screening for DM and prediabetes was found to be cost-savi
ng among patients at risk compared with no screening.5 Nevertheless, a targeted screening app
roach based on risk assessment and stratification of high-risk subjects should be undertaken to
 optimize resource allocation and utilization.6 
In order to stratify high-risk subjects for DM screening, risk algorithms for the detection
 of undiagnosed DM have been developed and validated in different populations and healthcar
e settings.6–9 However, these risk score algorithms are population specific; the combination of 
risk factors in each algorithm varies across countries, ethnicities, and levels of income based o
n the population in which these algorithms were developed. For the Chinese population,10–13 
most of the risk algorithms11–13 were derived from results of laboratory tests, in addition to so
ciodemographic and anthropometric data. Interestingly, the majority of these Chinese DM risk
 algorithms were developed and validated in low income settings.10–12 Little is known about th
eir performance, calibration, and discrimination in the detection of undiagnosed DM among C
hinese populations in non-low income settings. Furthermore, no nomograms for the identificat
ion of undiagnosed DM have been developed, which would be an ideal, simple-to-use graphic
al tool to facilitate DM risk assessment and stratification in clinical practice and the communit
y setting. 
The aims of this study were to present and validate a non-laboratory- and laboratory-bas
ed risk assessment algorithm for detecting undiagnosed DM among the Chinese population in 
a non-low income setting. In addition, a simple and user-friendly nomogram was constructed t
o enable clinicians to estimate individual DM risk based on non-laboratory and laboratory risk
 assessment algorithms. Both tools could inform clinical decision making and enable identific
ation of individuals at high risk for DM to undergo further screening tests, thus promoting the 
early detection of DM in the clinical and community settings. In addition, the study provides i
nformation on modifiable risk factors to be targeted by health intervention programs for the re
duction of individual DM risk.  
 
<A>Methods 
<B>Subjects for the development of risk assessment algorithms 
This study was part of a Hong Kong professional driver community project to promote health 
awareness and literacy regarding DM. Details regarding subject recruitment, eligibility criteri
a, and interviews have been reported previously.14–16 
Subjects were excluded if they self-reported to have clinician-diagnosed DM. For each e
ligible subject, we retrieved DM risk factor data, including sociodemographic characteristics, 
lifestyle, past medical history and family history, which were surveyed through structured inte
rview questionnaires. Sociodemographic data included the age, gender, and marital status of t
he subjects. For lifestyle factors, we considered self-reported drinking status, smoking status, 
and exercise frequency. For past medical history, gestational DM was defined by self-reported
 high blood glucose levels during pregnancy in women without a known diagnosis of DM. A s
elf-reported history of hypertension was recorded. A positive family history of DM was define
d as either first-degree (parents or siblings) or second-degree (grandparents) relatives having 
DM. 
In addition, anthropometric and laboratory assessments were performed on each subject 
at baseline. For anthropometric assessment, we measured body mass index (BMI), systolic bl
ood pressure (SBP), diastolic blood pressure (DBP), and waist circumference. Blood samples 
were taken for the measurement of FPG and 2-h post-load plasma glucose in the 75-g OGTT t
o determine glycemic status, as well as to determine the full lipid profile, including triglycerid
es (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-densit
y lipoprotein cholesterol (LDL-C), to assess DM risk. Plasma glucose, TG, TC, and HDL-C w
ere measured using the Abbott Architect c16000 chemistry analyzer, whereas LDL-C was deri
ved from the Friedewald formula.  
Undiagnosed DM was defined as subjects with FPG ≥7.0 mmol/L or 2-h post-load plas
ma glucose ≥11.1 mmol/L in the 75-g OGTT. 
 
<B>Development and validation of risk assessment algorithms 
In all, 3357 subjects completed the questionnaire survey and underwent anthropometric and la
boratory assessment during the study period. Simple random sampling was performed to selec
t 2518 subjects from the total number of subjects (75% of the total sample) as the developmen
t sample. The remaining 25% formed the validation sample. 
Data from the development sample (n = 2518) on the following DM risk factors were us
ed to develop the risk assessment model: (i) sociodemographic and lifestyle risk factors, inclu
ding age (<45, ≥45–<50, ≥50–<55, ≥55–<60, and ≥60 years), gender, smoking status (active s
moker), and exercise frequency; (ii) non-laboratory clinical risk factors, including family hist
ory of DM, history of hypertension, obesity (BMI ≥25 kg/m2), central obesity (waist circumfe
rence ≥80 cm for women and ≥90 cm for men), and uncontrolled blood pressure (SBP ≥140 m
mHg or DBP ≥90 mmHg); and (iii) laboratory risk factors, including TG, TC, HDL-C, and LD
L-C. Sociodemographic and non-laboratory clinical risk factors were used for the developmen
t of the non-laboratory-based risk assessment algorithm. Laboratory risk factors were added to
 sociodemographic and non-laboratory clinical risk factors for the development of the laborato
ry-based risk assessment algorithm.  
Based on undiagnosed DM as the outcome, significant risk factors with P < 0.05 in a ste
pwise binary logistic regression model were retained in the final risk assessment model. Each 
risk factor was assigned a weighting in the risk score using respective β-coefficients multipli
ed by 10 and rounded to the nearest integer. The risk score for each subject would be the sum 
of risk score contributed by each risk factor identified by the final risk assessment model. 
Non-laboratory- and laboratory-based risk assessment algorithms were validated externa
lly using data for the remaining 839 subjects in the validation sample; these subjects had not b
een used for algorithm development. The accuracy, calibration, and discrimination of the risk 
algorithms to detect undiagnosed DM were compared against six previously published DM ris
k assessment algorithms,10,12,13, 17–19 of which three were developed in Chinese populations (N
ew Chinese Diabetes Risk Score,10 Qingdao Diabetes Risk Score,12 and Southern Chinese Ris
k Score13). 
 
<B>Design of a nomogram 
Both risk assessment algorithms were then converted into a nomogram (Fig. 1). With regard t
o the design of the nomogram, the score for each characteristic for each subject was mapped d
irectly on the nomogram using the rule located at the top of the nomogram (Fig. 1). The score
s obtained for each characteristic are summed to compute the total DM risk score based on the
 risk assessment algorithm. Total DM risk scores are mapped in the lower part of the nomogra
m to predict the prevalence of undiagnosed DM. 
 
<B>Data analysis 
Descriptive statistics of baseline characteristics between development and validation samples 
were compared using independent t-tests for continuous variables and Chi-squared tests for ca
tegorical variables.  
Risk algorithms were developed and modeled using a stepwise binary logistic regressio
n model. The goodness-of-fit of the two models was assessed by Akaike information criterion 
(AIC) and Bayesian information criterion (BIC) statistics, with the lower values indicating bet
ter fit. For each risk algorithm, Youden’s index was used to determine the optimal cut-off valu
e for detecting undiagnosed DM.20 Accuracy in terms of sensitivity and specificity of the use 
of risk algorithms at optimal cut-off values for detecting undiagnosed DM were compared wit
h diagnosis confirmed by FPG or OGTT as the diagnostic standard. The Hosmer–Lemeshow 
χ2 statistic and area under the receiver operating characteristic (ROC) curve (AUC) were use
d to assess the calibration and discrimination of these risk algorithms.  
All analyses were conducted using SPSS version 20.0 for Windows (IBM Inc., Chicago,
 IL, USA) and STATA version 13 (STATA Corporation, College Station, TX, USA). Two-side
d P < 0.05 was considered significant. 
 
<A>Results 
Descriptive characteristics of the 3357 study subjects overall and by analysis samples are pres
ented in Table 1. Of 3357 subjects without a prior history of DM, 271 (8.1%) had undiagnose
d DM. The prevalence of undiagnosed DM between the development and validation samples 
did not differ significantly (8.3% vs 7.3%; P = 0.325). The mean (± SD) age of subjects was 5
0.9 ± 7.6 years. Most subjects were male (92.7%) and non-smokers (80.5%). In terms of non-l
aboratory-based clinical characteristics, 31.4% of subjects had a family history of DM, 51.2%
 had general obesity, 48.1% had central obesity, and 32.2% had uncontrolled blood pressure w
ith either SBP >140 mmHg or DBP >90 mmHg; 12.8% of subjects had history of hypertensio
n and the subjects in the validation sample were more likely to have hypertension than those i
n the development sample. There were no significant differences in laboratory-based clinical c
haracteristics between the development and validation samples. 
For model development based on stepwise binary logistic regression (non-laboratory- vs
 laboratory-based), there was a significant association between undiagnosed DM and increasin
g age for each 5-year stratum from 45 to 60 years (β-coefficient 0.49–1.10 vs 0.19–1.12), ge
neral obesity (β-coefficient 0.45 vs 0.35), a positive family history of DM in a first- or secon
d-degree relative (β-coefficient 0.72 vs 0.70), exercising regularly (β-coefficient 0.60 vs 0.5
7), and uncontrolled blood pressure (β-coefficient 0.54 vs 0.0.52). Abnormal TG was signific
antly associated with undiagnosed DM in the regression analysis for the laboratory-based risk 
assessment algorithm. Significant risk factors were used to assign weighted scores, and the tot
al risk score for each subject was the sum of all risk scores allocated to each individual risk fa
ctor. The scores for non-laboratory- and laboratory-based risk assessment algorithms ranged fr
om 0 to 33 and from 0 to 37, respectively. Youden’s index suggesting the optimal cut-off valu
e for undiagnosed DM was 18 for both risk assessment algorithms. At the optimal cut-off valu
e ≥18, the sensitivity and specificity were 57.9% and 68.9%, respectively, for the non-laborato
ry-based algorithm and 66.2% and 60.2%, respectively, for the laboratory-based algorithm. 
For the external validation of models, the AUC for the non-laboratory- and laboratory-b
ased algorithms was 0.709 and 0.711, respectively, supporting model discrimination. The Hos
mer–Lemeshow test with P > 0.05 (0.229 and 0.483, respectively) indicated adequate calibrati
on of the non-laboratory- and laboratory-based algorithms. Using the validation sample, the se
nsitivity and specificity at the optimal cut-off value ≥18 for the non-laboratory-based risk algo
rithm were 63.9% and 67.7%, respectively, whereas those of the laboratory-based risk algorith
m were 72.1% and 57.8%, respectively.  
Compared with existing risk algorithms, the risk algorithms developed in the present stu
dy exhibited adequate accuracy, discrimination, and calibration. Figure 1 shows the nomogra
m that graphically calculated the non-laboratory- and laboratory-based risk scores. The lower 
part of the nomogram shows the predicted probability of the individual having undiagnosed D
M in both routine clinical practice and the community setting. From the nomogram, the predic
ted prevalence of undiagnosed DM increases gradually from 1% at a total risk score of 0 to 34
% at a total risk score of 33. 
 
<A>Discussion 
The present study developed and validated simple non-laboratory- and laboratory-based risk a
ssessment algorithms for predicting undiagnosed DM in the general Chinese population. Base
d on the risk assessment algorithms, we developed a simple-to-use nomogram (Fig. 1) for pri
mary care clinicians to facilitate risk sharing in such a way that high-risk subjects are identifie
d to promote the uptake of DM screening. In addition to risk information sharing, this risk ass
essment facilitates the health service provider prioritizing DM prevention strategies and launc
hing DM screening in the primary care setting when resources for glycemic testing are limited.
 Moreover, risk stratification identified high-risk subjects, who were then encouraged to under
go DM screening using the most appropriate screening test. Screened subjects were empower
ed to increase their awareness of DM and to make lifestyle modifications. 
Risk scores with cut-off values ≥18 had the best combination of sensitivity and specifici
ty for detecting undiagnosed DM. Therefore, subjects with risk scores ≥18 were considered to
 be high-risk subjects recommended to undergo DM screening. Visualization of the nomogra
m has important implications for clinicians and subjects. For example, the predicted probabilit
y of undiagnosed DM is approximately 15% if subjects score 23 on the non-laboratory-based 
risk assessment algorithm. 
The National Prevalence Health Survey of 46 239 adults in 14 provinces in China found
 that the prevalence of undiagnosed DM was 6.3%,21 and a survey conducted in a nationally re
presentative sample of 98 658 Chinese adults reported a prevalence of 8.1% in 2010.22 The pr
evalence of undiagnosed DM found in the development (8.3%) and validation (7.3%) samples
 in the present study is comparable to that in the Chinese population. Thus, the prevalence of u
ndiagnosed DM in the present study was comparable to the Hong Kong prevalence of 9.51%, 
as estimated by the International Diabetes Federation.23  
The non-laboratory-based risk assessment algorithm was constructed on the basis of fiv
e widely recognized risk factors: age, BMI, family history of DM, exercise frequency, and blo
od pressure. This is in line with recent systematic reviews7,8 of newly developed risk assessme
nt algorithms reporting that the frequently included risk factors are age and BMI, representing
 measures of body mass. Age group was a main contributor to the risk score for the detection 
of undiagnosed DM, because we observed a trend for increasing risk score with increasing ag
e. Interestingly, there were two modifiable risk factors recognized in our algorithms: BMI and
 exercise frequency. This implies that health intervention programs, such as body weight moni
toring and control and lifestyle interventions, are useful in reducing DM risk in asymptomatic 
subjects in the Chinese population.  
Although the risk factors identified in our algorithms are mostly found in existing algori
thms summarized by systematic reviews,7,8 there are no existing risk algorithms using the sam
e pool of risk factors. Risk factors may be presented in other forms and using alternative defin
itions. It should be highlighted that there is no universal consensus regarding the combination 
of risk factors to be used for the detection of undiagnosed diabetes. Notably, the risk algorith
ms developed in one country may not be transferable to other counties, reflected by the poor a
bility to calibrate and discriminate the external dataset. For example, two risk algorithms12,13 d
eveloped using the Chinese population did not have satisfactory performance, with an AUC of
 ≥0.7 in our dataset upon external validation; this could be due, in part, to differences in inco
me levels. However, recent studies24,25 have not found any clear indication that the addition of
 ethnicity improves the performance of risk algorithms for predicting diabetes. Therefore, furt
her research is required to improve the performance through the additional effects of alternati
ve key information, such as spousal history of diabetes.26 
A high degree of model discrimination does not necessarily imply identification of true 
positive diabetes cases. Upon external validation of existing algorithms developed using Cauc
asian populations, the AUC of the algorithm of Bang et al. was <0.7.17 Even though the discri
mination of another two algorithms18,19 was greater than that of our algorithms, those algorith
ms did not achieve a good trade-off between sensitivity and specificity at predefined optimal c
ut-off values. For both algorithms,18,19 the specificities were unacceptably low although the se
nsitivities were at least 90%. Hence, a high degree of discrimination does not necessarily lead 
to reasonable performance at recommended cut-off values. In such cases, when an algorithm h
as a high degree of discrimination upon external validation, new recommended cut-off values 
may help balance sensitivity and specificity.  
The laboratory-based risk assessment algorithm increased the number of risk factors by 
including factors such as TG; however, this algorithm may not be able to stratify risks of asy
mptomatic subjects without prior laboratory testing. Nevertheless, such an algorithm is likely 
to be used when identifying high-risk subjects in the routine clinical setting, where blood sam
ples are routinely collected for lipid profile assessment. 
 
<B>Limitations 
Several limitations of present study should be noted. First, our risk algorithms were developed
 and validated using Chinese data, so they may not be generalizable to non-Chinese populatio
ns. However, only two previous studies27,28 included ethnicity in their algorithms, indicating t
hat ethnicity is not a common predictive factor for the prediction of diabetes. Second, there w
as a high proportion (92.7%) of male professional drivers in our development and validation s
amples. 
 
<B>Conclusions 
In summary, validated risk assessment algorithms were developed for the prediction of undiag
nosed DM in a Chinese population. A corresponding simple-to-use nomogram was constructe
d to facilitate risk information sharing and to promote targeted screening for DM among high-
risk individuals in the primary care and community settings. Future studies on the evaluation 
of our risk algorithms and nomogram to examine the feasibility and validity of their use in tar
geted community-based screening for DM are warranted.  
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Figure 1 Nomogram to predict the probability of undiagnosed diabetes based on non-labora
tory- and laboratory-based risk algorithms. The patient’s score for each parameter is plotted o
n the appropriate scale and vertical lines are drawn to the line of points to obtain the correspo
nding scores. All scores are summed to obtain a total points score. The total points score is plo
tted on the total points line and a vertical line is drawn down to the bottom line. The correspon
ding value shows the predicted probability of undiagnosed diabetes. 
 
Table 1 Sociodemographic and clinical characteristics of subjects without a known history o
f diabetes in the model development and validation samples 
 Total (n = 3357) Model development sam
ple (n = 2518) 
Model validation sa
mple (n = 839) 
P-value 
Sociodemographic characteristics     
Age (years)    0.113 
<45 637 (19.0%) 501 (19.9%) 136 (16.2%)  
≥45 and <50 767 (22.8%) 571 (22.7%) 196 (23.4%)  
≥50 and <55 789 (23.5%) 595 (23.6%) 194 (23.1%)  
≥55 and <60 747 (22.3%) 541 (21.5%) 206 (24.6%)  
≥60 417 (12.4%) 310 (12.3%) 107 (12.8%)  
Gender    0.816 
Female 246 (7.3%) 183 (7.3%) 63 (7.5%)  
Male 3111 (92.7%) 2335 (92.7%) 776 (92.5%)  
Exercise regularly 1480 (44.1%) 1089 (43.3%) 391 (46.6%) 0.092 
Smoking 653 (19.5%) 485 (19.3%) 168 (20.0%) 0.629 
Clinical characteristics     
Undiagnosed diabetes 271 (8.1%) 210 (8.3%) 61 (7.3%) 0.325 
Family history of diabetes 1053 (31.4%) 778 (30.9%) 275 (32.8%) 0.310 
Gestational diabetesA 19 (7.7%) 17 (9.3%) 2 (3.2%) 0.117 
Hypertension 429 (12.8%) 305 (12.1%) 124 (14.8%) 0.045* 
WC (cm) 89.1 ± 8.2 89.0 ± 8.3 89.5 ± 8.2 0.105 
Central obesity (WC ≥90 cm men; 
≥80 cm women) 
1616 (48.1%) 1196 (47.5%) 420 (50.1%) 0.198 
BMI (kg/m2) 25.4 ± 3.4 25.3 ± 3.4 25.6 ± 3.4 0.094 
General obesity (BMI ≥25 kg/m2) 1719 (51.2%) 1270 (50.4%) 449 (53.5%) 0.122 
SBP (mmHg) 132.4 ± 15.9 132.2 ± 15.9 133.0 ± 16.1 0.242 
DBP (mmHg) 80.3 ± 10.7 80.1 ± 10.7 80.8 ± 10.7 0.113 
Suboptimal BP (SBP >140 or DBP 
>90 mmHg) 
1082 (32.2%) 810 (32.2%) 272 (32.4%) 0.893 
FPG (mmol/L) 5.4 ± 1.4 5.4 ± 1.5 5.3 ± 1.2 0.160 
TG (mmol/L) 1.7 ± 1.3 1.7 ± 1.3 1.7 ± 1.1 0.997 
TC (mmol/L) 5.4 ± 1.0 5.4 ± 1.0 5.4 ± 0.9 0.470 
HDL-C (mmol/L) 1.2 ± 0.3 1.2 ± 0.3 1.2 ± 0.3 0.652 
LDL-C (mmol/L) 3.5 ± 0.9 3.5 ± 0.9 3.5 ± 0.8 0.477 
Data are given as the mean ± SD or as the number of subjects with percentages in parentheses
. Asterisks indicate a significant difference (P < 0.05) between the development and validatio
n samples (independent t-test or Chi-squared test, as appropriate). 
AOnly for women (n = 246). 
BMI, body mass index; BP, blood pressure; SBP, systolic BP; DBP, diastolic BP; TC, total ch
olesterol; TG, triglycerides; FPG, fasting plasma glucose; WC, waist circumference. 
 
Table 2 Risk factors and their respective risk scores for non-laboratory- and laboratory-base
d risk assessment algorithms based on the development sample 
Factors Non-laboratory-based algorithm Laboratory-based algorithm 
β-Coefficient OR 95% (CI) P-value Score β-Coefficient OR 95% (CI) P-value Score 
Age (years)           
<45 – 1 – – 0 – 1 – – 0 
≥45 and <50 0.49 1.63 (0.98, 2.73) 0.061 5 0.49 1.63 (0.98, 2.73) 0.062 5 
≥50 and <55 0.58 1.79 (1.08, 2.97) 0.024* 6 0.59 1.80 (1.09, 2.99) 0.022* 6 
≥55 and <60 0.83 2.30 (1.39, 3.80) 0.001* 8 0.84 2.31 (1.39, 3.83) 0.001* 8 
≥60 1.10 3.02 (1.74, 5.23) <0.001* 11 1.12 3.06 (1.76, 5.30) <0.001* 11 
BMI (kg/m2)           
<25 – 1 – – 0 – 1 – – 0 
≥25 0.45 1.56 (1.16, 2.11) 0.003* 4 0.35 1.43 (1.05, 1.94) 0.024* 4 
Family history of diabetes         
No – 1 – – 0 – 1 – – 0 
Yes 0.72 2.05 (1.53, 2.75) <0.001* 7 0.70 2.02 (1.51, 2.71) <0.001* 7 
Exercise regularly          
Yes – 1 – – 0 – 1 – – 0 
No 0.60 1.82 (1.34, 2.48) <0.001* 6 0.57 1.76 (1.29, 2.41) <0.001* 6 
Suboptimal blood pressure         
No – 1 – – 0 – 1 – – 0 
Yes 0.54 1.71 (1.28, 2.30) <0.001* 5 0.52 1.69 (1.25, 2.27) 0.001* 5 
Triglyceride (mmol/L)          
<1.7 Not considered – 1 – – 0 
≥1.7 0.43 1.53 (1.14, 2.07) 0.005* 4 
Goodness-of-fit           
AIC 1, 381 1, 375 
BIC 1, 433 1, 433 
AIC, Akaike information criterion; BIC, Bayesian information criterion; BMI, body mass ind
ex; CI, confidence interval; OR, odds ratio. 
Table 3 Accuracy, discrimination and calibration of the risk algorithms developed in the present study and existing risk algorithms using the de
velopment (internal validation) and validation (external validation) samples 
Risk algorithm Optimal cut-off value (ra
nge) 
AUC (95% CI) Sensitivity (%) at cut-off v
alue (95% CI) 
Specificity (%) at cutoff 
value (95% CI) 
Hosmer–Lemeshow te
st 
Present study  
 Internal validation (n = 2518)      
  Non-laboratory-based algorithm 18 (0–33) 0.686 (0.650, 0.722) 57.9 (51.8, 63.9) 68.9 (67.3, 70.6) 0.159 
  Laboratory-based algorithm 18 (0–37) 0.696 (0.661, 0.731) 66.2 (59.4, 72.6) 60.2 (58.2, 62.2) 0.053 
 External validation (n = 839)  
  Non-laboratory-based algorithm 18 (0–33) 0.709 (0.646, 0.773) 63.9 (50.6, 75.8) 67.7 (64.3, 71.0) 0.229 
  Laboratory-based algorithm 18 (0–37) 0.711 (0.648, 0.774) 72.1 (59.2, 82.9) 57.8 (54.3, 61.3) 0.483 
Existing algorithms      
 New Chinese Diabetes risk score [10] 25 (0–51) 0.708 (0.644, 0.772) 98.4 (91.2, 100.0) 15.0 (12.6, 17.7) 0.730 
 Qingdao Diabetes risk Score [12] Men 17 (3–32) 
Women 14 (3–32) 
0.672 (0.602, 0.742) 75.4 (62.7, 85.5) 53.1 (49.5, 56.6) 0.383 
 Southern Chinese Risk score [13] 16 (0–30) 0.664 (0.595, 0.734) 49.2 (36.1, 62.3) 75.2 (72.0, 78.2) 0.208 
 Spanish Diabetes Risk score [18] 100 (unspecified) 0.728 (0.669, 0.788) 100.0 (94.1, 100.0) 0.1 (0.0, 0.7) 0.935 
 Patient Self-Assessment score [17] 5 (-1–9) 0.675 (0.607, 0.743) 37.7 (25.6, 51.0) 82.5 (79.7, 85.1) 0.986 
 TOPICS Diabetes Screening score [19] 8 (0–16) 0.723 (0.663, 0.784) 91.8 (81.9, 97.3) 33.2 (29.9, 36.6) 0.320 
NA, not applicable; AUC, area under the receiver operating characteristic curve; TOPICS, Toranomon Hospital Health Management Center Stud
y; CI, confidence interval. 
